INTRODUCTION
During influenza virus A infection, an inflammatory response occurs in airway epithelia and the inflammatory cytokines and chemokines released at this time have been studied. In vitro studies have concentrated on the infection of macrophage and epithelial cell lines. The cytokines interferon (IFN)-a/b, tumour necrosis factor (TNF)-a, interleukin (IL)-1 and IL-6, and the mononuclear cell attractant chemokines macrophage inflammatory protein (MIP)-1a [CCL3; the new classification system for chemokines (Zlotnik and Yoshie, 2000) is used throughout this paper], MIP-1b (CCL4), monocytic chemoattractant protein (MCP)-1 (CCL2), MCP-3 (CCL7), interferoninducible protein (IP)-10 (CXCL10) and regulated on activation, normal T cell-expressed and -secreted protein (RANTES, CCL5) have been found in influenza virusinfected cultures of human monocytes, rat alveolar cells and murine macrophages (Bussfeld et al., 1998; Hofmann et al., 1997; Matikainen et al., 2000; Nain et al., 1990) . In contrast, IL-8 (CXCL8) production is suppressed in human monocytes infected with A/Puerto Rico/8/34 (A/PR/8/34) (Hofmann et al., 1997) . In vivo, influenza virus priming of monocytes causes induction and enhanced immigration of mononuclear cells into infected tissue (Kaufmann et al., 2001) but the response to respiratory infection with virus is largely polymorphonuclear (Toms et al., 1977) . It is possible that infection of epithelial cells promotes this response. In the normal healthy respiratory epithelium, immunologically competent cells make up less than 2 % of the cell population (Danel et al., 1996) . An increase of immunologically competent cells occurs after infection perhaps as a result of cytokines/chemokines secreted by epithelial cells. Cytokine/chemokine expression and release has been demonstrated in epithelial cells infected with influenza A virus in vitro, in particular for IL-6, CXCL8 and CCL5, (Choi and Jacoby, 1992; Arndt et al., 2002; Adachi et al., 1997; Matsukura et al., 1996 Matsukura et al., , 1998 and possibly CCL2 (see Julkunen et al., 2000) .
The inflammatory response in influenza contrasts with the observation that influenza virus infection results in cell death with the characteristics of apoptosis, hereafter referred to as apoptosis, which should act to prevent an inflammatory response (Raff, 1998) . Apoptosis is induced by influenza virus infection in vitro in many cell types, e.g. HeLa and Madin-Darby canine kidney (MDCK) cells (Takizawa et al., 1993) , lymphocytes (Hinshaw et al., 1994; Nichols et al., 2001) , murine 3T3 fibroblasts (Balachandran et al., 2000) , neutrophils (Colamussi et al., 1999; Engelich et al., 2001) , and also in vivo in mice (Mori et al., 1995; Technau-Ihling et al., 2001) and chickens (Ito et al., 2002) . Apoptosis involves the upregulation of Fas (Takizawa et al., 1995) , which can be activated by the dsRNA-activated protein kinase R (PKR) and regulated by double-stranded RNA (Balachandran et al., 1998; Tan and Katze, 1999) . Fas ligand (FasL), which is upregulated on the cell surface following infection, may also play a role (Fujimoto et al., 1998; Raff, 1998) . Apoptosis can also be induced by the activation of latent transforming growth factor (TGF)-b on the surface of virus-infected cells, and in the extracellular matrix. Influenza virus neuraminidase (NA) cleaves latent TGF-b into its active form and influenza virus-induced apoptosis is reduced by neutralizing TGF-b antibodies Schultz-Cherry & Hinshaw, 1996) . In addition, influenza virus-induced apoptosis can be partially blocked by NA inhibitors, although it is likely that one or more intracellular processes are also involved in apoptotic induction (Morris et al., 1999 . In murine 3T3 cells and MDCK cells, Fas-activated apoptosis is due to influenza A virus infection triggering the recruitment of the Fas-associated death domain (FADD) and caspase-8, which activate downstream caspase proteolysis (Balachandran et al., 2000; Takizawa et al., 1999) .
Despite the fact that apoptosis is considered to be an antiinflammatory event, there is increasing evidence that the processes of apoptosis and inflammatory mediator release may be interlinked in infection. Shigella infection of mast cells releases IL-1a/b and CXCL8, and this is dependent on the cells undergoing apoptosis (Sansonetti et al., 2000) . Apoptosis activates the processing of intracellular stores of these cytokines by caspase-1 (also known as interleukin 1-converting enzyme or ICE) from their precursors to their active form (Zychlinsky et al., 1994) . This has also been shown for influenza virus infection of macrophages (Pirhonen et al., 1999 (Pirhonen et al., , 2001 . Here, we investigated whether influenza A virus-induced apoptosis of a human nasal and bronchiolar cell line positively or negatively modulated cytokine release by these cells.
METHODS
Cells and viruses. The influenza virus clone 7a (H3N2) of the reassortant virus A/Puerto Rico/8/34 (H1N1) 6 A/England/939/69 (H3N2) was grown in 10-day old embryonated hens' eggs as described previously (Price et al., 1997) . The human nasal septum squamous carcinoma cell line RPMI-2650 (ATCC) was grown in 90 % Eagle's minimum essential medium (EMEM) supplemented with 2 mM L-glutamine, 0?225 % sodium bicarbonate, 100 IU penicillin ml 21 , 100 mg streptomycin ml 21 , 1 mM sodium pyruvate (Sigma) and 10 % foetal calf serum (FCS) (BioWhittaker). The human muco-epidermoid bronchiolar carcinoma cell line NCI-H292 (ATCC) was grown in 90 % RPMI-1640 medium supplemented with 2 mM L-glutamine, 0?225 % sodium bicarbonate, 100 IU penicillin ml 21 , 100 mg streptomycin ml 21 (Life Technologies), 3?6 M glucose (Fisher Scientific), 10 mM HEPES (Sigma), 1 mM sodium pyruvate (Sigma). MDCK-NBL2 cells were grown in 90 % EMEM supplemented as above. Post-infection, cells were maintained in 98 % modified medium with 2 % serum.
Infection of cells for measurement of infection, apoptosis
and cytotoxicity. RPMI-2650 and NCI-H292 cells were seeded on 9 mm coverslips in 48-well flat-bottomed plates using 0?3 ml diluted cell suspension, or directly into the wells of 6-well plates using 3 ml diluted cell suspension, and allowed to grow to confluence overnight. Monolayers were then washed twice in PBS, virus (5 EID 50 per cell) in PBS was added and the plates were incubated at 37 uC for 1 h. PBS was added to uninoculated control wells. After incubation, virus was removed, the monolayers were washed three times with PBS and the plates incubated at 37 uC in 5 % CO 2 in a humidified atmosphere with 0?3 ml of maintenance medium until the time point for analysis.
Measurement of numbers of infected cells. The number of infected RPMI-2650 and NCI-H292 cells was determined as described previously (Price et al., 1997) using the influenza virus A/X31 (H3N2) nucleoprotein (NP) mouse monoclonal antibody NP 147 (kindly provided by A. Douglas, NIMR, UK) as the primary antibody and goat anti-mouse IgG-FITC conjugate (Sigma) as the secondary antibody. Propidium iodide (PI; Sigma) (1 mg ml 21 in PBS) was used as the nuclear stain. Coverslips were mounted on glass slides using DABCO/glycerol anti-fade mountant. Infected cells were identified by the presence of green fluorescence from the FITC molecule within them.
Measurement of apoptosis. Apoptosis was quantified using the TUNEL (TdT-mediated dUTP nick-end labelling) method (Boehringer Mannheim), following the manufacturer's instructions, which preferentially labels DNA strand breaks in apoptotic cells with the dye tetramethyl rhodamine (TMR). The nuclear counterstain used was DAPI (Boehringer Mannheim) and the percentage of apoptotic cells was determined by counting the number of DAPIpositive (whole cell population) and TUNEL-TMR-positive (apoptotic) cells under an UV microscope.
Cytotoxicity assay. Cytotoxicity assays of infected cells were conducted using the Cytotox 96 kit (Promega) as described previously (Price et al., 1997) .
Calculation of total % apoptotic and infected cells. The percentage of dead cells as determined by the cytotoxicity assay was combined with the percentage of apoptotic cells (determined by TUNEL) on the monolayer to give the total percentage of apoptotic cells, i.e. those that had lysed and detached from the monolayer plus those that were apoptotic but remained on the monolayer, as described previously (Mohsin et al., 2002) . Similarly, the percentage of cells found dead by the cytotoxicity assay was combined with the percentage of infected cells (determined by fluorescence microscopy) on the monolayer to give the total percentage of infected cells.
Inhibition of apoptosis using specific inhibitors. Cell monolayers were treated with pan-caspase (Z-VAD-fmk), caspase-8 (Z-IETD-fmk), caspase-9 (Z-LEHD-fmk) inhibitors (all from R and D Systems, Abingdon, UK) or the reactive oxygen species (ROS) inhibitor butylated hydroxyanisole (BHA) (Sigma) 12 h pre-inoculation with virus and immediately after incubation with virus at a concentration of 100 mM, previously shown to be the optimum concentration. The inhibitor was replenished 24 h post-infection (p.i.) in assays that went on longer than this time.
Measurement and quantification of Golgi fragmentation. To show Golgi body and endoplasmic reticulum (ER) morphology, NCI-H292 cells were fixed in methanol at 220 uC for 5 min. Cells were then incubated for 30 min at room temperature with primary rabbit anti-human GM130 (Golgi) or anti-human PDI (protein disulfide isomerase, ER) (1 : 300 in PBS/0?5 % BSA) (kindly provided by Dr. M. Lowe, University of Manchester) antibodies. Secondary antibody visualization of the primary antibodies was carried out using goat anti-rabbit IgG Molecular Probes Alexa fluor 568 at a 1 : 1000 dilution (2 mg ml 21 ) (Cambridge Biosciences). Nuclear counterstain DAPI (1 mg ml 21 in methanol) was used to determine apoptosis by morphology and cell nucleus localization. This protocol was used in conjunction with staining for infection, as above.
RNA extraction and semi-quantitative RT-PCR for cytokine/ chemokine mRNA. RPMI-2650 and NCI-H292 cells were grown in 6-well plates and, when confluent, infected at an m.o.i. of 5 EID 50 per cell or mock-infected with PBS. At the relevant time point p.i./ stimulation, 1?5 ml of the maintenance medium was removed to an Eppendorf tube for assay by ELISA (see section below) and the rest discarded. Total RNA extraction was performed by the guanidinium thiocyanate method (Chomczynski and Sacchi, 1987) using TriReagent (Sigma). RT-PCR was performed as follows. All reagents were from Promega unless stated otherwise. A 20 ml reverse transcription (RT) reaction was set up on ice in a 0?5 ml Eppendorf using 10 mg of RNA eluate, 1 mg oligo(dT) 15mer primer and made up to 11 ml with DEPC-treated distilled H 2 O. This solution was spun briefly for 5 s at 8500 g, boiled for 2 min and replaced on ice. Added to this was 16 RT buffer (50 mM KCl, 10 mM MgCl 2 , 50 mM DTT, 0?5 mM spermidine and 50 mM Tris/HCl, pH 8?3), 0?5 mM of each dNTP (MBI Fermentas), 20 units of RNAsin and 5 units of avian myeloblastosis virus reverse transcriptase (AMV RT). The RT reaction was performed on a Mastercycler gradient thermocycler (Eppendorf) and run at 25 uC for 10 min, 42 uC for 1 h and 99 uC for 10 min and placed on ice or stored at 220 uC until used. Negative RT controls, which lacked either AMV RT or sample RNA, were treated similarly. PCR was performed on 5 ml of RT cDNA product in a 50 ml reaction containing forward and reverse (sense and anti-sense) primers (25 pM) (synthesized by MWG Biotech), 16 PCR buffer (20 mM Tris/HCl pH 8?4, 50 mM KCl) (Gibco-BRL), 1?5 mM MgCl 2 , 0?5 mM of each dNTP, made up to 49?5 ml with DEPC-treated distilled H 2 O and 2?5 units of Thermus aquaticus YT1 (Taq) DNA polymerase (Gibco-BRL). Negative RT and RNA controls were subject to the same conditions and negative PCR controls were run with 5 ml distilled H 2 O instead of cDNA. The thermal cycling program was performed on the same machine as the RT using the following program: initial denaturation at 95 uC for 1 min then x cycles (see primer references) of 95 uC for 45 s, annealing (see primer references) for 45 s, extension at 75 uC for 45 s; then 4 uC until ready for visualization. Primers and conditions used for each set were as published previously. The primer sequences and information were obtained from the following references: b-actin, IFN-c, IL-1b, IL-6, CXCL8, TGF-b1, TNF-a (Nilsen et al., 1998) , IL-18 (Tomita et al., 2001) , IFN-b (Ronni et al., 1995) , CCL5 (Matsukura et al., 1998) and CCL2 (Beck et al., 1999) . PCR products were run on 100 ml 1 or 2 % agarose/16 TBE gels containing 1 mg of ethidium bromide for visualization on an ultraviolet transilluminator. They were run as 10 ml samples with 16 loading dye (2 ml of 66 loading dye), alongside a 100 bp DNA ladder (New England Biosciences) at 100 V for approximately 1 h.
Cytokine ELISA analysis. ELISA for cytokines IL-1b, IL-6, CXCL8, CCL2 and CCL5 (R and D systems, Abingdon, UK) or IL-18 (MBL, distributed by R and D Systems) were carried out by following the manufacturer's instructions. Samples were diluted up to 10006 or 56 for IL-6 or CXCL8 assays respectively. The plates were read on a microplate reader at 450 nm, and again at 540 nm for correction by subtraction of the reading at 540 nm from that at 450 nm. Standard curves were constructed on GRAPHPAD prism software and sample concentration was determined by linear regression analysis.
Generation of NCI-H292 GRASP65-GFP stable cell lines.
NCI-H292 cells grown in 6-well plates were transfected with wildtype or caspase-resistant rat GRASP65-pEGFP-N2 constructs, kindly provided by Dr. M. Lowe, University of Manchester, using LipofectAMINE PLUS (Invitrogen/Life Technologies) according to the manufacturer's instructions. Transfected cells were grown in the presence of geneticin (G418) until clonal colonies had grown. These were trypsinized off the wells and grown separately in 75 cm 2 tissue culture flasks. Once confluent the cells were trypsinized and seeded on 9 mm glass coverslips in 48-well plates. The cells were stained for anti-GM130 as above and analysed by fluorescence microscopy for co-localization of GFP and Alexa fluor 568 fluorescence indicating insertion of the expressed protein into the Golgi body. Once this had been confirmed cells were maintained as per untransfected NCI-H292.
Statistical analysis. The Student's t-test and 2-way analysis of variance (ANOVA) with replicates was used to analyse data.
RESULTS
Levels of infection and apoptosis in nasal and bronchiolar cells infected with clone 7a Fig. 1(a-c) illustrates apoptosis in influenza virus-infected nasal cells. Infection of nasal cells was first observed 12 h p.i. (Fig. 1d) . Most (85 %) of the cells inoculated with virus were infected at 12 h p.i. and this increased little with time (maximum 95 % 36-60 h p.i.). Apoptosis was barely detectable at 12 h p.i. but subsequently began to increase, reaching a maximum of~50 % 36-60 h p.i. (Fig. 1d) . Interestingly, not all infected cells became apoptotic. Similarly, infection of bronchiolar cells was first observed 12 h p.i. and the level of infection (~45 %) did not markedly increase with time (maximum~65 % at 48 h p.i.) (Fig. 1e) . In nasal cells 50 % of infected cells became apoptotic whilst in bronchiolar cells 100 % of infected cells became apoptotic.
Cytokine response to influenza A virus infection of epithelial cells
The expression and release of several pro-inflammatory cytokines by nasal and bronchiolar cells after clone 7a infection was examined using RT-PCR and ELISA. The level of expression of b-actin was used as an internal standard for RT-PCR. The cytokines/chemokines expressed in the nasal epithelial cell line (IL-18, CCL2, CCL5) were expressed constitutively (Fig. 2a) . mRNA for IL-1b, IL-6, CXCL8, TGF-b and TNF-a could not be detected in infected or uninfected nasal cells (data not shown).
IL-1b, IL-6 and CXCL8 were expressed constitutively in uninfected bronchiolar cells, whilst CCL2 and CCL5 were not expressed (Fig. 2b) . In addition, CCL2 and CCL5 expression was induced at 6 and 24 h p.i. respectively. The expression of IL-1b, IL-6 and CXCL8 mRNA was not increased above their constitutive levels as observed in uninfected cells (Fig. 2b) . Expression of IL-18, TNF-a and TGF-b could not be detected in uninfected or clone 7a-infected cells (data not shown).
Supernatants of mock-infected and infected cells from both the human nasal and human bronchiolar cell lines were examined for released cytokine by ELISA. Mock-infected cells and infected nasal cells did not release detectable levels of any cytokine (IL-1b, IL-6, CXCL8, IL-18, CCL2, CCL5, data not shown). Similarly, IL-1b, IL-18 and CCL2 were not released by either uninfected or infected bronchiolar cells. However, IL-6, CXCL8 and CCL5 were released in significant amounts at late time points p.i. (Fig. 3) . Release of IL-6 was first detected 24 h p.i. with large amounts, approximately 60 ng ml
21
, present in cell culture supernatants by 48 h p.i. (Fig. 3a) . CXCL8 release appears to occur later, between 24 h and 48 h p.i., although there is a large amount present by this time, approximately 20 ng ml 21 (Fig. 3b) . CCL5 release began between 6 and 24 h p.i. and increased significantly (P<0?02) at 48 h p.i. to approximately 1200 pg ml 21 (Fig. 3c) .
Effect of caspase inhibitors on apoptosis
In bronchiolar cells the pan-caspase inhibitor (Z-VADfmk), which inhibits caspases-1, -3, -6 and -7, had a marked effect, reducing apoptosis by up to 75 % (P<0?01), whilst the caspase-8 inhibitor (Z-IETD-fmk) reduced apoptosis by 67 % (P<0?01) (Fig. 4a) . The caspase-9 (Z-LEHD-fmk) and ROS BHA inhibitors had little or no effect (Fig. 4a) . In contrast, in nasal cells the greatest amount of inhibition (~40 %) occurred with BHA (Fig. 4b) . No inhibition was observed with Z-LEHD-fmk while Z-IETD-fmk and Z-VAD-fmk reduced apoptosis only by~20 % and~25 %, respectively (Fig. 4b) .
The caspase inhibitors were dissolved in DMSO and BHA in ethanol, both of which can inhibit the generation of ROS, but infected cells treated with DMSO or ethanol at the same dilution as used in the inhibitor-treated samples had no effect on influenza virus-induced apoptosis ( Fig. 4a and b) . Interestingly, in both cell lines, Z-VAD-fmk reduced spontaneous apoptosis and so did Z-IETD-fmk in uninfected bronchiolar cells (Fig. 4a and b) , indicating that these caspases are involved in spontaneous apoptosis. The level of infection in both types of cells remained unaffected by any of these treatments and thus the reduction in apoptosis could not be attributed to a reduction in infection (data not shown).
Effect of caspase inhibitors on proinflammatory cytokine release and expression
Treatment of infected cells with the caspase-8 inhibitor Z-IETD-fmk and the downstream pan-caspase inhibitor Z-VAD-fmk did not increase viral titres (data not shown), despite inhibiting the induction of apoptosis, which is at variance with the hypothesis that virus-induced apoptosis is an antiviral event (Fig. 4b) . Therefore, these inhibitors were used to examine their effect on cytokine release (Fig. 5a) . Treatment of influenza virus-infected bronchiolar cells with Z-VAD-fmk, significantly increased the release of IL-6, CXCL8 and CCL5 compared to clone 7a alone (P<0?01 in each case) (Fig. 5a ). Z-IETD-fmk also increased cytokine/ chemokine release (P<0?02 in each case). BHA had no significant effect. Thus, virus-induced apoptosis limits the amount of pro-inflammatory cytokines released by infected bronchiolar epithelial cells.
IL-6 and CXCL8 mRNA expression remained at constitutive levels following treatment with caspase inhibitors (Fig. 5b) . However, CCL5 mRNA expression, which was barely detectable in untreated infected cells (Fig. 5b) , appeared to be greater in the presence of the inhibitor and expression was prolonged presumably because of increased cell survival. Z-VAD-fmk was better able to rescue mRNA expression than was Z-IETD-fmk. 
Influenza A virus-induced apoptosis is associated with fragmentation of the Golgi ribbon
While the increased release of CCL5 correlated with increased CCL5 mRNA levels (Fig. 5b) , the increased levels of IL-6 and CXCL8 released did not, as mRNA was expressed at similar levels in treated or untreated infected cells. A possible explanation for this is that secretory organelle morphology may be disrupted during apoptosis.
Recently it has been shown that the Golgi ribbon fragments during apoptosis due to caspase-3 dependent cleavage of the stacking protein GRASP65 (Lane et al., 2002) and caspase-2 dependent cleavage of Golgin-160 (Mancini et al., 2000) . Fragmentation of the Golgi ribbon may prevent secretion of mature cytokines by the cell during infection-induced apoptosis. In uninfected cells the ER can be seen to be in a juxtanuclear and cytoplasmic network (Fig. 6a) , whilst the Golgi is a defined ribbon-like structure (Fig. 6b) . In infected cells undergoing apoptosis, the structure of the ER remains stable until late apoptosis (secondary lysis) when the cell begins to decompartmentalize and collapse (Fig. 6c) . Unlike the ER, the Golgi ribbon fragmented away from its juxtanuclear position in small, scattered pieces (Fig. 6d) . Golgi ribbon fragmentation could be rescued by Z-VADfmk and to a lesser extent by Z-IETD-fmk (Fig. 7) , although some fragmentation was seen, representing a more abundant intermediate stage of mixed ribbon and scattered fragments (data not shown as any scattering was considered indicative of fragmentation due to active caspases). However, many more cells were visible on the caspaseinhibited monolayers and therefore many more with a complete or near complete Golgi ribbon, when compared with clone 7a-infected cells (data not shown), indicating inhibition of caspases rescues cleavage of this particular secretory organelle. In contrast, Z-LEHD-fmk, the caspase-9 inhibitor that could not abrogate apoptosis in this system, was also unable to rescue Golgi morphology. Thus, we have shown that the Golgi body is a major target of caspases in influenza A virus-induced apoptosis, acting possibly to halt secretion of pro-inflammatory cytokines as well as other secreted proteins.
Caspase-resistant GRASP65 protects IL-6 and CXCL-8 secretion
The Golgi protein GRASP65 has been shown to be important for higher order structure of the Golgi cisternae and is cleaved by caspase-3 during apoptosis. This also occurs during influenza A virus-induced apoptosis in human bronchiolar epithelial cells (Fig. 6d) and is rescued by pan-caspase and caspase-8 inhibitors (Fig. 7) . To assess whether this cleavage was responsible for perturbation of IL-6 and CXCL8 release the bronchiolar cells (NCI-H292) were stably transfected with wild-type (wtH292) or caspaseresistant GRASP65 (3DH292) in an EGFP vector. The caspase-resistant GRASP65 has mutations at three sites normally cleaved by caspase-3 that prevent this occurring (Lane et al., 2002) . Double staining with antibody to Golgi and localization of GFP expressed as a fusion protein with GRASP65 indicated that both wtH292 and GRASP65 (3DH292) localized to the Golgi (data not shown).
Approximately 70-80 % of the cells expressed GFP, indicating that they were stably transfected. After infection of the cells, supernatants were collected at 48 h p.i. and analysed for CCL5, IL-6 and CXCL8 content.
Both ) and CXCL8 ( Fig. 8b ) levels were significantly higher in supernatants of 3DH292 than wtH292 or untransfected H292 cells (P<0?02 and P<0?01 respectively). However, levels were also increased in wtH292 compared to H292 cells, suggesting that integration of more copies of the gene causes more protein to be expressed which counteracts caspase cleavage, or that the transfection process itself stimulates some cytokine release. CCL5 levels were not protected and indeed its secretion significantly decreased in both wtH292 and 3DH292 cells compared to untransfected H292 cells (P<0?02). It appears that transcription is more important for the CCL5 response and suggests that its production is uncoupled from the IL-6 and CXCL8 response.
DISCUSSION
Influenza virus induces apoptosis in human respiratory cells of nasal and bronchiolar origin. However, apoptosis is generally regarded as a mechanism that limits the inflammatory response as apoptotic cells are phagocytosed and destroyed before they liberate their cellular contents. This contrasts with observations in humans and ferrets that influenza is associated with a profound inflammatory response in the respiratory airways (Toms et al., 1977) . This general conclusion that apoptosis is anti-inflammatory has been questioned recently for Shigella infection (Zychlinsky et al., 1994; Zychlinsky & Sansonetti, 1997a, b) . In this case, caspase-1 (ICE) is the critical regulator and its activation leads to the processing of intracellular stores of IL-1 and IL-18. Thus, infection of an immune cell may lead to a pro-inflammatory response despite the cell undergoing apoptosis. Interestingly caspase-1 deficient mice develop normally, indicating that this caspase may be intrinsic to defence against infection and is not required in developmental apoptosis (Sansonetti et al., 2000) . Similarly, influenza A virus infected macrophages/monocytes, known to undergo apoptosis, also produce IL-1 and IL-18 in this manner (Julkunen et al., 2000 (Julkunen et al., , 2001 Matikainen et al., 2000; Pirhonen et al., 1999 Pirhonen et al., , 2001 .
Could this happen with influenza virus-infected respiratory epithelial cells? In response to influenza A virus infection epithelial cells including bronchiolar and lung cells produce a limited number of cytokines such as the type I interferons (IFN-a/b) and IL-6 and chemokines such as CCL5, CCL2 and CXCL8 (Adachi et al., 1997; Julkunen et al., 2000 Julkunen et al., , 2001 Matsukura et al., 1996) . We have confirmed the release of IL-6, CXCL8 and CCL5 in this study but have also shown that CCL2 mRNA is expressed but the cytokine is not released in detectable quantities. However, most importantly, inhibition of caspase activation and hence apoptosis causes an increase in the release of pro-inflammatory cytokines. Thus, influenza A virus-induced apoptosis does act to limit the pro-inflammatory cytokine response, but not by the accepted mechanism. However, induction of apoptosis is insufficient to repress the pro-inflammatory response to infection, once engaged. In contrast, no cytokines were released from nasal cells.
The results obtained here are important in the context of the innate immune response during influenza. Influenza A virus infection and replication occurs primarily in the upper respiratory tract of humans where the respiratory epithelial cell is the dominant cell type present when compared to intraepithelial leukocytes (Danel et al., 1996) , so virus infection and the specific response will occur primarily in these cells. However, nasal cells apparently do not release pro-inflammatory cytokines and thus it is unclear how the inflammatory response is initiated at this site. Either the nasal cell line examined here is not a good model for the in vivo situation or the small number of phagocytes present in nasal tissue perform the function. Studies with other nasal cell lines or primary nasal tissue are required to clarify this. The limiting of the inflammatory response in the narrow lower airways may be extremely important for the pathogenesis of the virus as this could have profound effects on respiration. Blockage of the narrow airways of the upper respiratory tract of neonatal ferrets following clone 7a infection can be lethal whereas infection with a less virulent virus, which induced less of an inflammatory response, was not lethal (Collie et al., 1980; Husseini et al., 1983) . In another scenario, a virus that induces less apoptosis may cause indirect tissue damage due to elevated proinflammatory cytokine release. Conversely, if a consequence of virus-induced apoptosis in the lower respiratory tract is a reduction in the release of pro-inflammatory cytokines, and therefore a reduction in the immune response, then the virus may spread further down the respiratory tree to hinder oxygen exchange and allow fluid leakage in to the lungs, resulting in pneumonia. These are important points that warrant further study.
Although inhibition of infected cells undergoing apoptosis may simply buy more time for the cells to release cytokines, how is it that apoptotic cells hinder the release of cytokines?
The downstream targets of caspases are many. As in staurosporine-treated HeLa cells (Lane et al., 2002) , the Golgi ribbon fragments during influenza A virus-induced, caspase-8 dependent apoptosis. One protein cleaved by the host cell caspases is the Golgi stacking protein GRASP65 (Lane et al., 2002) . Another is Golgin-160 (Mancini et al., 2000) , although its function is unknown. The loss of higher order Golgi structure can be rescued significantly, but not completely, by expression of a caspase-resistant mutant, GRASP65 (Lane et al., 2002) . The Golgi is an important organelle through which cytokines must pass during the process of secretion. Why it is necessary to fragment the Golgi body during ligand/chemically stimulated apoptosis is not known (Lane et al., 2002) but in the case of influenza virus, it may be to disrupt the secretion of pro-inflammatory mediators, the production of which is stimulated by the infection. Another virus that limits pro-inflammatory cytokine secretion via its 3A protein is poliovirus (Dodd et al., 2002) . However, this is due to an inhibition of ER-toGolgi traffic and not through apoptosis (Dodd et al., 2002; Doedens et al., 1997) . Thus, viruses have evolved different methods of suppressing the pro-inflammatory innate response.
The decrease in CCL5 mRNA production during influenza A virus-induced apoptosis is reversed in the presence of caspase inhibitors indicating that apoptosis may be affecting transcription, possibly through PKR phosphorylation of eIF-2a. However, in bronchiolar cells CCL5 production is regulated by the p38 MAPK/ERK/JNK pathway, and possibly by ROS as secondary messengers (Kujime et al., 2000) . The same pathway has also been implicated in influenza A virus-induced apoptosis (Lin et al., 2001) . How this pathway mediates an apoptotic response at the same time as CCL5 production, which is reduced by the apoptotic response, is unknown and awaits further research.
It is, therefore, important to identify the virion components that induce apoptosis as the pathway activated appears to vary little between cell lines. NA can induce apoptosis by facilitating the release of TGF-b (Schultz-Cherry and Hinshaw, 1996) , but replication dependent events are also required as UV inactivated virus that retains NA activity has reduced capacity to cause apoptosis (Morris et al., 1999) . The M1 protein also interacts with caspase-8 but it is not clear whether this is as an inhibitor or activator (Timofeeva et al., 2001; Zhirnov et al., 2002b) . The NS1 protein has also been associated with an anti-apoptotic effect using a virus with a deleted ns1 gene (Zhirnov et al., 2002a) , possibly relating to its PKR inhibitory activity (Lu et al., 1995; Katze, 1998, 1999) . Recently a new protein was found to be encoded by a second reading frame in the PB1 protein of influenza A virus (Chen et al., 2001) . This protein, PB1-F2, induces apoptosis by a cytochrome c-dependent method, particularly in T cells. How it causes apoptosis and why it is T cell specific has yet to be elucidated.
What is clear is that there is mounting evidence to show that influenza viruses induce apoptosis and, from this study, that apoptosis may regulate the cytokine response in virus infection. Studies that reveal how the virus induces and modulates these responses should help to clarify the complex relationship between them and their relevance to the pathogenesis of the virus in vivo, and in particular that of virulent strains with pandemic potential.
